T80.810 Catégorie · précision supplémentaire requise Extravasation of vesicant antineoplastic chemotherapy
ICD-10-CM T80.810 identifies “Extravasation of vesicant antineoplastic chemotherapy” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 19: Injury, poisoning and certain other consequences of external causes
Instructions du code
Inclusion terms1
Infiltration of vesicant antineoplastic chemotherapy
Instructions des niveaux supérieurs
Chapitres 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T80-T88 · Complications of surgical and medical care, not elsewhere classified (T80-T88)
Excludes 221
- any encounters with medical care for postprocedural conditions in which no complications are present, such as:
- artificial opening status (Z93.-)
- closure of external stoma (Z43.-)
- fitting and adjustment of external prosthetic device (Z44.-)
- burns and corrosions from local applications and irradiation (T20-T32)
- complications of surgical procedures during pregnancy, childbirth and the puerperium (O00-O9A)
- mechanical complication of respirator [ventilator] (J95.850)
- poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)
- postprocedural fever (R50.82)
- specified complications classified elsewhere, such as:
- cerebrospinal fluid leak from spinal puncture (G97.0)
- colostomy malfunction (K94.0-)
- disorders of fluid and electrolyte imbalance (E86-E87)
- functional disturbances following cardiac surgery (I97.0-I97.1)
- intraoperative and postprocedural complications of specified body systems (D78.-, E36.-, E89.-, G97.3-, G97.4, H59.3-, H59.-, H95.2-, H95.3, I97.4-, I97.5, J95.6-, J95.7, K91.6-, L76.-, M96.-, N99.-)
- ostomy complications (J95.0-, K94.-, N99.5-)
- postgastric surgery syndromes (K91.1)
- postlaminectomy syndrome NEC (M96.1)
- postmastectomy lymphedema syndrome (I97.2)
- postsurgical blind-loop syndrome (K91.2)
- ventilator associated pneumonia (J95.851)
Use additional code3
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
- code(s) to identify the specified condition resulting from the complication
- code to identify devices involved and details of circumstances (Y62-Y82)
T80 · Complications following infusion, transfusion and therapeutic injection
Includes1
complications following perfusion
Excludes 27
- bone marrow transplant rejection (T86.01)
- febrile nonhemolytic transfusion reaction (R50.84)
- fluid overload due to transfusion (E87.71)
- posttransfusion purpura (D69.51)
- transfusion associated circulatory overload (TACO) (E87.71)
- transfusion (red blood cell) associated hemochromatosis (E83.111)
- transfusion related acute lung injury (TRALI) (J95.84)
Seventh character1
The appropriate 7th character is to be added to each code from category T80
A — initial encounter
D — subsequent encounter
S — sequela
T80.81 · Extravasation of vesicant agent
Inclusion terms1
Infiltration of vesicant agent
Codes plus précis
T80.810AExtravasation of vesicant antineoplastic chemotherapy, initial encounterCode facturable et spécifiqueT80.810DExtravasation of vesicant antineoplastic chemotherapy, subsequent encounterCode facturable et spécifiqueT80.810SExtravasation of vesicant antineoplastic chemotherapy, sequelaCode facturable et spécifiqueRéférences de l’index officiel
Références de l’index officiel (2)
Extravasation (1)
- Extravasation › vesicant agent › antineoplastic chemotherapyIndex des maladies
Infiltrate, infiltration (1)
- Infiltrate, infiltration › vesicant agent › antineoplastic chemotherapyIndex des maladies
Historique
Historique du code
Dernière modification enregistrée · FY2025 · 04-01
En vigueur dès le
- Instructions héritées modifiées
Extravasation of vesicant antineoplastic chemotherapy
Catégorie — choisir un code plus précis
CDC/NCHS · FY2025 · 04-01Toutes les éditions (19)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2016 | 2015-10-01 | Première observation |
| FY2017 | 2016-10-01 | Instructions héritées modifiées |
| FY2018 | 2017-10-01 | Aucun changement tabulaire |
| FY2019 | 2018-10-01 | Aucun changement tabulaire |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Instructions héritées modifiées |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Explorez les codes plus précis de cette catégorie. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.